
Nanomaterials Mediated Enhancement of CAR-T for HCC: Revolutionizing Immunotherapy Strategies
Introduction Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer and is a leading cause of cancer-related mortality worldwide.1,2 HCC is often diagnosed at an advanced stage, where treatment options are limited, and prognosis is …